Admission Date:  [**2129-4-3**]              Discharge Date:   [**2129-4-12**]  Date of Birth:  [**2052-12-16**]             Sex:   F  Service: NEUROLOGY  Allergies: Diflucan  Attending:[**First Name3 (LF) 57490**] Chief Complaint: seizure  Major Surgical or Invasive Procedure: Lumbar Puncture x2   History of Present Illness: 76 year old AA woman who was transferred from [**Hospital3 417**] hospital for management of seizures and possible intracranial mass vs. bleed.
Her abdominal area and torso seems to have swelled and she has had weight loss of about ten pounds over the last six to seven weeks with poor appetite.
She was refered to OMED for o/p bone marrow bx.
During this visit she was found to have acute renal failure (Cre 6.8) and hypercalcemia (12.5) and was directly admitted to the OMED service.
She was treated with decadron and alkaline fluids.
She rece'd total of 5 plasmaphareses and continued on steriods.
She was discharged [**3-30**] on decadron with bactrim for PCP and [**Name9 (PRE) 38229**] prophylaxis.
When he went to give her medications at 6:00 last night, he found her sitting on the floor next to the bed (as if she had fallen out of bed).
She was given dilaudid, ativan (1mg) and dilantin (1g).
Patient was LP'd, given Ceftriaxone 2gram IV, dilantin 1gram IV, Decadron 4mg IV, and FFP for mild coagulopathy (INR 1.4).
Past Medical History: -recently diagnosed IgD myeloma and hypercalcemia -colon CA Duke's C2 s/p resection in [**2111**]; normal C-scope in [**2125**] except for diverticulosis -thalassemia trait, microcytic anemia -HTN -gout  Social History: She is married for the last 14 years.
Fundi could not be visualized secondary to miosis.
Sensation: Withdraws and localizes pain in UE  Reflexes:       B T Br Pa Ach Right 2 2 2  3  2 Left  2 2 2  3  2 brisk throughout Toes were upgoing on left, mute on right Coordination: unable to assess  PHYSICAL EXAM TODAY   Pertinent Results: [**2129-4-3**] 08:25AM   CK(CPK)-250* [**2129-4-3**] 08:25AM   cTropnT-0.13* [**2129-4-3**] 08:25AM   CK-MB-6 [**2129-4-3**] 08:25AM   PHENYTOIN-13.9 [**2129-4-3**] 08:25AM   PT-14.9* PTT-28.0 INR(PT)-1.4 [**2129-4-3**] 06:30AM CEREBROSPINAL FLUID (CSF)  PROTEIN-82* GLUCOSE-60 [**2129-4-3**] 06:30AM CEREBROSPINAL FLUID (CSF)  WBC-5 RBC-[**2114**]* POLYS-94 BANDS-1 LYMPHS-4 MONOS-1 [**2129-4-3**] 06:30AM CEREBROSPINAL FLUID (CSF)  WBC-5 RBC-2370* POLYS-93 LYMPHS-5 MONOS-2 [**2129-4-3**] 04:00AM   PT-15.0* PTT-28.6 INR(PT)-1.4 [**2129-4-3**] 12:35AM   GLUCOSE-103 UREA N-56* CREAT-5.0* SODIUM-137 POTASSIUM-3.5 CHLORIDE-102 TOTAL CO2-25 ANION GAP-14 [**2129-4-3**] 12:35AM   ALT(SGPT)-7 AST(SGOT)-30 CK(CPK)-245* ALK PHOS-82 AMYLASE-122* TOT BILI-1.0 [**2129-4-3**] 12:35AM   LIPASE-90* [**2129-4-3**] 12:35AM   cTropnT-0.23* [**2129-4-3**] 12:35AM   CK-MB-8 [**2129-4-3**] 12:35AM   TOT PROT-5.4* ALBUMIN-3.9 GLOBULIN-1.5* CALCIUM-8.2* MAGNESIUM-2.1 [**2129-4-3**] 12:35AM   ACETONE-POSITIVE [**2129-4-3**] 12:35AM   WBC-12.7* RBC-3.19* HGB-8.7* HCT-26.9* MCV-85 MCH-27.4 MCHC-32.5 RDW-15.7* [**2129-4-3**] 12:35AM   NEUTS-95.1* BANDS-0 LYMPHS-2.6* MONOS-1.9* EOS-0.4 BASOS-0 [**2129-4-3**] 12:35AM   HYPOCHROM-1+ ANISOCYT-NORMAL POIKILOCY-NORMAL MACROCYT-1+ MICROCYT-NORMAL POLYCHROM-NORMAL [**2129-4-3**] 12:35AM   PLT SMR-NORMAL PLT COUNT-184 [**2129-4-3**] 12:35AM   PT-15.1* PTT-28.6 INR(PT)-1.4 [**2129-4-3**] 12:30AM URINE  COLOR-Straw APPEAR-Clear SP [**Last Name (un) 155**]-1.011 [**2129-4-3**] 12:30AM URINE  BLOOD-LGE NITRITE-NEG PROTEIN-TR GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG [**2129-4-3**] 12:30AM URINE  RBC-[**7-8**]* WBC-[**4-2**] BACTERIA-FEW YEAST-NONE EPI-1  Head CT showed: 1) Right parafalcine parietal hyperdense areas representing hemorrhage, perhaps into a mass, or related to a vascular process.
Recommend MRI with gadolinium for further evaluation.
NEURO: The patient was admitted to the neuro ICU for evaluation of ICH and seizure management.
She received empiric antibiotic coverage with vanco/ceftriaxone/acyclovir until CSF culture negatives.
For seizure control, she was initially treated with dilantin, but was later transitioned to Keppra.
She will be discharged on a Decadron taper.
She will continue Keppra for seizure prevention.
She started her 2nd steroid pulse for multiple myeloma and completed 4 days of high dose Decadron (10mg q 6h).
She had a thyroid and renal US to further evaluate.
RENAL: ARF secondary to cast nephropathy due to light chain production.
Continue low K diet, renal dose medications.
Repeated troponin trended down.
Metoprolol increased to 100mg po BID and Amlodipine 10mg po QD added to control hypertension.
Will continue to monitor BP with goal SBP<140 and increase meds as needed to maintain this pressure.
HEME: -She received 2 Units of PRBCs on [**4-8**] for Hct 25.
-mild coagulopathy: likely poor PO and early vitamin K deficiency.
Repleated with subcutaneous vitamin K. INR now 1,2.
Triamcinolone 0.025 % Cream [**Hospital1 **] (2 times a day) PRN for breast rash.
Oxycodone HCl 5-10 mg PO Q4-6H PRN 3.
Pantoprazole 40 mg PO Q24H 4.
Metoprolol Tartrate 25 mg PO BID 5.
Docusate Sodium 100 mg PO BID 6.
Bisacodyl 10 mg PO DAILY as needed.
Allopurinol 100 mg PO EVERY OTHER DAY 8.
Trimethoprim-Sulfamethoxazole 160-800 mg Tablet PO QMOWEFR 9.
Isoniazid 300 mg PO DAILY 10.
Pyridoxine HCl 50 mg PO DAILY 11.
Decadron 4 mg PO once a day for 10 doses.
Trimethoprim-Sulfamethoxazole 80-400 mg Tablet Sig: One (1) Tablet PO QMOWEFR (Monday -Wednesday-Friday).
Pantoprazole Sodium 40 mg Tablet, Delayed Release (E.C.)
Levetiracetam 500 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Metoprolol Tartrate 50 mg Tablet Sig: Two (2) Tablet PO BID (2 times a day).
Amlodipine Besylate 5 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Insulin Regular Human 100 unit/mL Solution Sig: One (1) Injection ASDIR (AS DIRECTED).
Decadron 0.5 mg Tablet Sig: Eight (8) Tablet PO every eight (8) hours: Taper dose as follows: 8 tablets q8h for 2 days, then re-start decadron pulse (see Rx).
Oxycodone HCl 5 mg Tablet Sig: One (1) Tablet PO Q4-6H (every 4 to 6 hours) as needed.
Decadron 4 mg Tablet Sig: 2.5 Tablets PO every six (6) hours for 16 doses: Please begin on Thursday, [**4-14**].
Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Discharge Instructions: Please continue to take your medications as directed.
You should continue to take Keppra to prevent seizures.
